HYDROCORTISONE AND ACETIC ACID

HYDROCORTISONE AND ACETIC ACID was reported 43 times

HYDROCORTISONE AND ACETIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DACRYOCANALICULITIS 1 0.0085
1 EUSTACHIAN TUBE DISORDER 1 0.0042
2 TEETHING 1 0.0033
3 CHANGE IN SUSTAINED ATTENTION 1 0.0033
4 ANISOCORIA 1 0.0026
5 URINARY TRACT DISCOMFORT 1 0.0022
6 MAGNESIUM DEFICIENCY 1 0.0021
7 INSULIN-LIKE GROWTH FACTOR DECREASED 1 0.0019
8 COMPULSIONS 1 0.0015
9 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
10 SERRATIA INFECTION 1 0.0013
11 EYELID EXFOLIATION 1 0.0013
12 BINGE EATING 1 0.0009
13 INFUSION SITE IRRITATION 1 0.0008
14 INFUSION SITE RASH 1 0.0007
15 CATAPLEXY 1 0.0007
16 ANKLE OPERATION 1 0.0007
17 EAR HAEMORRHAGE 1 0.0005
18 COMPULSIVE SHOPPING 1 0.0005
19 WEIGHT ABNORMAL 1 0.0004
20 CARTILAGE INJURY 1 0.0004
21 ABDOMINAL INFECTION 1 0.0004
22 FUNGAL SKIN INFECTION 1 0.0002
23 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
24 DRUG EFFECT DELAYED 1 0.0002
25 VARICOSE VEIN 1 0.0002
26 FOOD CRAVING 1 0.0002
27 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
28 INJECTION SITE DISCHARGE 1 0.0002
29 ERYTHEMA OF EYELID 1 0.0002
30 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
31 PROSTATIC DISORDER 1 0.0002
32 URINE ODOUR ABNORMAL 1 0.0002
33 INJECTION SITE VESICLES 1 0.0002
34 INFUSION SITE EXTRAVASATION 1 0.0002
35 SWELLING OF EYELID 1 0.0002
36 FOOD ALLERGY 1 0.0001
37 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
38 FACIAL PARALYSIS 1 0.0001
39 PRODUCT CONTAINER ISSUE 1 0.0001
40 MUSCLE STRAIN 1 0.0001
41 EXOSTOSIS 1 0.0001
42 PRODUCT PACKAGING ISSUE 1 0.0001
43 EAR PAIN 2 0.0001
44 DRY THROAT 1 0.0001
45 EUPHORIC MOOD 1 0.0001
46 INITIAL INSOMNIA 1 0.0001
47 EAR DISCOMFORT 1 0.0001
48 RIB FRACTURE 2 0.0001
49 EYE DISCHARGE 1 0.0001
50 GLOSSODYNIA 2 0.0001
51 ACCIDENT 1 0.0001
52 WRIST FRACTURE 1 0.0001
53 ADRENAL INSUFFICIENCY 1 0.0001
54 INJECTION SITE URTICARIA 2 0.0001
55 SPINAL OPERATION 1 0.0001
56 JOINT RANGE OF MOTION DECREASED 1 0.0001
57 OSTEOPENIA 1 0.0001
58 ULCER 1 0.0001
59 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
60 MIDDLE INSOMNIA 1 0.0001
61 SLEEP APNOEA SYNDROME 1 0.0001
62 CHOKING 1 0.0001
63 BLOOD PRESSURE ABNORMAL 1 0.0001
64 RETCHING 1 0.0000
65 POOR QUALITY SLEEP 1 0.0000
66 DEVICE DISLOCATION 2 0.0000
67 ORAL PAIN 1 0.0000
68 THERAPY NON-RESPONDER 2 0.0000
69 OCULAR HYPERAEMIA 2 0.0000
70 FIBROMYALGIA 1 0.0000
71 RESPIRATORY TRACT INFECTION 1 0.0000
72 ANHEDONIA 1 0.0000
73 EAR INFECTION 1 0.0000
74 ABNORMAL DREAMS 1 0.0000
75 PROCEDURAL PAIN 1 0.0000
76 PAIN IN JAW 1 0.0000
77 EYE IRRITATION 2 0.0000
78 BLOOD POTASSIUM DECREASED 1 0.0000
79 EYE DISORDER 1 0.0000
80 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
81 EYE PRURITUS 1 0.0000
82 COVID-19 5 0.0000
83 HEART RATE DECREASED 1 0.0000
84 INFLUENZA 3 0.0000
85 EYE SWELLING 1 0.0000
86 INTESTINAL OBSTRUCTION 1 0.0000
87 PSORIATIC ARTHROPATHY 1 0.0000
88 POLLAKIURIA 1 0.0000
89 SKIN EXFOLIATION 2 0.0000
90 DEVICE LEAKAGE 1 0.0000
91 INTENTIONAL PRODUCT MISUSE 2 0.0000
92 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
93 BLOOD CHOLESTEROL INCREASED 1 0.0000
94 RASH ERYTHEMATOUS 1 0.0000
95 ILLNESS 2 0.0000
96 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
97 DISTURBANCE IN ATTENTION 1 0.0000
98 ABDOMINAL DISCOMFORT 3 0.0000
99 URINARY TRACT INFECTION 3 0.0000
100 BONE PAIN 1 0.0000
101 INFUSION RELATED REACTION 1 0.0000
102 DRY SKIN 2 0.0000
103 INJECTION SITE PRURITUS 1 0.0000
104 RESPIRATORY FAILURE 1 0.0000
105 ASTHENIA 5 0.0000
106 UNEVALUABLE EVENT 1 0.0000
107 CHRONIC KIDNEY DISEASE 1 0.0000
108 INJECTION SITE SWELLING 1 0.0000
109 PARAESTHESIA 2 0.0000
110 INJECTION SITE BRUISING 1 0.0000
111 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
112 DRY MOUTH 1 0.0000
113 INSOMNIA 3 0.0000
114 GASTROINTESTINAL DISORDER 1 0.0000
115 OROPHARYNGEAL PAIN 1 0.0000
116 CHEST PAIN 2 0.0000
117 WEIGHT DECREASED 3 0.0000
118 DYSPHAGIA 1 0.0000
119 MIGRAINE 1 0.0000
120 PRODUCT DOSE OMISSION ISSUE 3 0.0000
121 SOMNOLENCE 2 0.0000
122 FALL 3 0.0000
123 SEPSIS 1 0.0000
124 SEIZURE 1 0.0000
125 DECREASED APPETITE 2 0.0000
126 CHILLS 1 0.0000
127 VOMITING 4 0.0000
128 EMOTIONAL DISTRESS 1 0.0000
129 VISUAL IMPAIRMENT 1 0.0000
130 INJECTION SITE ERYTHEMA 1 0.0000
131 PSORIASIS 1 0.0000
132 VISION BLURRED 1 0.0000
133 ANXIETY 2 0.0000
134 INFECTION 1 0.0000
135 HYPOAESTHESIA 1 0.0000
136 BLOOD PRESSURE INCREASED 1 0.0000
137 PAIN 4 0.0000
138 HOSPITALISATION 1 0.0000
139 CONFUSIONAL STATE 1 0.0000
140 PNEUMONIA 2 0.0000
141 URTICARIA 1 0.0000
142 MYALGIA 1 0.0000
143 NASOPHARYNGITIS 1 0.0000
144 PRODUCT USE ISSUE 1 0.0000
145 ANAEMIA 1 0.0000
146 PRURITUS 2 0.0000
147 FATIGUE 4 0.0000
148 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
149 ARTHRALGIA 2 0.0000
150 HYPERTENSION 1 0.0000
151 RASH 2 0.0000
152 WEIGHT INCREASED 1 0.0000
153 INCORRECT DOSE ADMINISTERED 1 0.0000
154 DYSPNOEA 2 0.0000
155 INJECTION SITE PAIN 1 0.0000
156 DIZZINESS 1 0.0000
157 DRUG INEFFECTIVE 2 0.0000
158 NAUSEA 1 0.0000
159 DEATH 1 0.0000